ArticleHuman vaccines & immunotherapeutics2026
Knowledge, perceptions, uptake, and determinants of HPV vaccination, and preferred delivery strategies among out-of-school girls in Masaka, Uganda.
Article in Human vaccines & immunotherapeutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
22 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cervical cancer is a leading cause of cancer-related mortality among women in sub-Saharan Africa, and accounts for 80% of female cancer cases in Uganda. The Human Papillomavirus (HPV) vaccine prevents cervical cancer but is mainly administered to school-going girls aged 9-15 y, potentially excluding out-of-school girls. This study assessed knowledge, perceptions, uptake, and preferred delivery strategies among out-of-school girls aged 9-20 y in inland and fishing communities in Masaka, Uganda. Between August and October 2024, we surveyed 428 girls (214 per community) using structured questionnaires. Descriptive statistics summarized participant characteristics, and logistic regression identified factors associated with uptake. The median age was 17 y (IQR: 15-19). Nearly one-fifth (19.9%) were married or cohabiting, and 62.4% had ever had sex. Less than half (44.2%) reported prior knowledge of the HPV vaccine, though most recognized its importance (73.4%) and safety (72.2%). Uptake remained low: 29.9% had received at least one dose, and 12.9% had completed two doses. Prior awareness strongly predicted uptake (aOR = 7.82; 95% CI: 4.67-13.44), with higher uptake in fishing communities (aOR = 2.21; 95% CI: 1.30-3.84). Lower uptake was associated with being out of school for 6-10 y (aOR = 0.24; 95% CI: 0.14-0.40) and prior sexual experience (aOR = 0.51; 95% CI: 0.27-0.96). Among unvaccinated girls, 91.2% expressed willingness to receive the vaccine. Preferred strategies included community outreaches (57.7%), health facility approaches (53.3%), and door-to-door delivery (29.2%). Uptake among out-of-school girls was low despite high willingness, underscoring the need for targeted interventions in high-risk settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.